Axsome Therapeutics Ownership | Who Owns Axsome Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Axsome Therapeutics Ownership Summary


Axsome Therapeutics is owned by 74.78% institutional investors, 15.38% insiders, and 9.85% retail investors. Vanguard group is the largest institutional shareholder, holding 8.33% of AXSM shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.71% of its assets in Axsome Therapeutics shares.

AXSM Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAxsome Therapeutics74.78%15.38%9.85%
SectorHealthcare Stocks 35.38%11.35%53.27%
IndustryBiotech Stocks 33.91%11.39%54.70%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group4.16M8.33%$760.66M
Blackrock funding, inc. /de3.91M7.87%$661.35M
Blackrock3.30M6.96%$265.65M
Fmr1.57M3.15%$264.85M
Price t rowe associates inc /md/1.32M2.65%$222.61M
Invesco1.30M2.61%$219.33M
Geode capital management1.16M2.34%$196.60M
Wellington management group llp1.15M2.30%$193.58M
Deep track capital, lp1.10M2.21%$185.92M
State street986.81K1.98%$166.79M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Alethea capital management649.11K56.28%$109.71M
Svb capital management33.85K12.95%$4.11M
Fairmount funds management815.18K8.91%$99.00M
Tri locum partners lp292.14K8.16%$35.48M
Iridian asset management llc/ct67.49K4.62%$11.41M
Pfm health sciences, lp264.30K4.07%$44.67M
Ghost tree capital150.00K3.78%$12.07M
First turn management188.77K3.56%$31.91M
Deep track capital, lp1.10M3.04%$185.92M
Arrowpoint investment partners (singapore) pte.16.40K2.46%$2.77M

Top Buyers

HolderShares% AssetsChange
First trust advisors lp577.48K0.07%534.07K
Norges bank495.46K0.01%495.46K
Point72 asset management424.75K0.09%406.75K
Assenagon asset management865.96K0.22%397.98K
Fmr1.57M0.01%385.37K

Top Sellers

HolderShares% AssetsChange
Macquarie group---1.08M
Ra capital management---1.00M
Rtw investments, lp---888.00K
Nationale-nederlanden powszechne towarzystwo emerytalne---278.83K
Iron triangle partners lp---252.27K

New Positions

HolderShares% AssetsChangeValue
Norges bank495.46K0.01%495.46K$90.49M
Vanguard fiduciary trust295.14K0.01%295.14K$49.88M
Healthcare of ontario pension plan trust fund97.55K0.03%97.55K$16.49M
Scout investments69.56K0.15%69.56K$5.60M
Hillsdale investment management53.36K0.25%53.36K$9.02M

Sold Out

HolderChange
Dunhill financial-1.00
Concord wealth partners-1.00
Atlantic union bankshares-1.00
Financial gravity asset management-1.00
Geowealth management-5.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20264220.24%37,198,853-1.17%741.32%211-6.64%14215.45%
Dec 31, 2025127-66.49%7,628,642-79.48%150.27%58-71.14%38-60.42%
Sep 30, 2025146-59.22%7,876,625-78.56%150.29%77-62.44%34-60.47%
Jun 30, 2025365-3.18%37,827,2692.24%761.33%2069.57%89-25.21%
Mar 31, 202519-94.14%7,027,292-81.11%140.24%8-94.97%9-90.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.39M2.71%30.12K
Vanguard US Total Market Shares ETF1.31M2.69%114.89K
Vanguard Small Cap Index1.00M1.96%30.58K
iShares Russell 2000 ETF974.05K1.89%8.22K
Macquarie Small Cap Core I651.89K1.31%-48.97K
Delaware Small Cap Core I579.64K1.21%-3.59K
Vanguard Small Cap Growth Index Inv561.87K1.10%21.41K
Bellevue Healthcare Ord506.57K1.06%506.57K
Invesco OFI Small Cap Growth482.52K0.94%42.81K
Invesco Discovery A482.52K0.94%20.24K

Recent Insider Transactions


DateNameRoleActivityValue
May 04, 2026Jacobson Mark L. Chief Operating OfficerSell$1.03M
May 05, 2026Jacobson Mark L. Chief Operating OfficerSell$53.17K
Apr 22, 2026Maizel Ari Chief Commercial OfficerSell$1.37M
Feb 26, 2026Coleman Mark-Sell$4.03M
Feb 26, 2026Jacobson Mark L. Chief Operating OfficerSell$5.73M

Insider Transactions Trends


DateBuySell
2026 Q2-3
2026 Q1-8
2025 Q4-10
2025 Q3313
2025 Q2-11

AXSM Ownership FAQ


Who Owns Axsome Therapeutics?

Axsome Therapeutics shareholders are primarily institutional investors at 74.78%, followed by 15.38% insiders and 9.84% retail investors. The average institutional ownership in Axsome Therapeutics's industry, Biotech Stocks , is 33.91%, which Axsome Therapeutics exceeds.

Who owns the most shares of Axsome Therapeutics?

Axsome Therapeutics’s largest shareholders are Vanguard group (4.16M shares, 8.33%), Blackrock funding, inc. /de (3.91M shares, 7.87%), and Blackrock (3.3M shares, 6.96%). Together, they hold 23.15% of Axsome Therapeutics’s total shares outstanding.

Does Blackrock own Axsome Therapeutics?

Yes, BlackRock owns 6.96% of Axsome Therapeutics, totaling 3.3M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 265.65M$. In the last quarter, BlackRock increased its holdings by 104.5K shares, a 3.27% change.

Who is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested?

Alethea capital management is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested, with 56.28% of its assets in 649.11K Axsome Therapeutics shares, valued at 109.71M$.

Who is the top mutual fund holder of Axsome Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Axsome Therapeutics shares, with 2.71% of its total shares outstanding invested in 1.39M Axsome Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools